Keyphrases
Acid Activation
12%
Amines
12%
Area under the Curve
12%
Beneficial Effects
12%
Bile Acids
100%
Binding Potential
12%
C-peptide
12%
Cholecystokinin
12%
Days of Treatment
12%
Farnesoid X Receptor
12%
Fibroblast Growth Factor 19 (FGF19)
25%
Gastric Emptying
25%
Glucagon
25%
Glucagon-like
25%
Glucose Metabolism
12%
Glucose-dependent Insulinotropic Polypeptide
12%
Glucose-lowering Drugs
100%
Gut Microbiota Composition
25%
Hyperphosphataemia
12%
Incretin Hormones
12%
Insulin
12%
Lipid Metabolism
12%
Lipids
12%
Lipogenesis
12%
Liquid Meal
12%
Meal Tolerance Test
12%
Mediating Effect
25%
Non-absorbable
12%
Placebo
25%
Plasma Glucose
25%
Randomized Controlled Trial
12%
Receptor Activation
12%
Resin
100%
Resting Energy Expenditure
25%
Sequester
100%
Sevelamer
100%
Type 2 Diabetic Patients
37%
Medicine and Dentistry
Bile Acid
100%
C-Peptide
12%
Cholecystokinin
12%
Farnesoid X Receptor
12%
Fibroblast Growth Factor 19
25%
Gastric Inhibitory Polypeptide
12%
Glucagon
25%
Glucagon Like Peptide 1
25%
Glucose Metabolism
12%
Gut Microbiota
25%
Hyperphosphatemia
12%
Incretin
12%
Lipid Metabolism
12%
Lipogenesis
12%
Patient with Type 2 Diabetes
37%
Placebo
25%
Randomized Controlled Trial
12%
Sevelamer
100%
Stomach Emptying
25%
Test Meal
12%
Biochemistry, Genetics and Molecular Biology
Bile Acid
100%
C-Peptide
16%
Cholecystokinin
16%
Farnesoid X Receptor
16%
Gastric Inhibitory Polypeptide
16%
Glucagon
33%
Glucagon Blood Level
16%
Glucagon-Like Peptide-1
33%
Glucose Blood Level
33%
Glucose Metabolism
16%
Incretin
16%
Intestine Flora
33%
Lipid
16%
Lipid Metabolism
16%
Lipogenesis
16%
Randomized Controlled Trial
16%
Resting Energy Expenditure
33%
Stomach Emptying
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Binding Potential
12%
C Peptide
12%
Cholecystokinin
12%
Farnesoid X Receptor
12%
Fibroblast Growth Factor 19
25%
Gastric Inhibitory Polypeptide
12%
Glucagon
25%
Glucagon-Like Peptide-1
25%
Hyperphosphatemia
12%
Incretin
12%
Intestine Flora
25%
Non Insulin Dependent Diabetes Mellitus
37%
Placebo
25%
Randomized Controlled Trial
12%
Sevelamer
100%